Pfizer Names Veteran Leader as Chief Medical Officer
Pfizer has appointed Patrizia Cavazzoni, the former head of the U.S. health regulator's drug evaluation unit, as its chief medical officer, marking a significant move to bolster its regulatory and drug safety operations under industry veteran leadership. Cavazzoni, who brings nearly two decades of experience from top pharmaceutical companies, will report to Chris Boshoff, Pfizer's chief scientific officer and R&D head. The appointment aims to strengthen the company's regulatory capabilities and address concerns over internal research and development.
- This strategic hire suggests that Pfizer is placing greater emphasis on building its in-house expertise to navigate complex regulatory landscapes and ensure compliance with evolving healthcare standards.
- How will the integration of Cavazzoni's team and her experience drive Pfizer's innovation in emerging areas, such as obesity treatment and personalized medicine?